Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

L-carnitine supplementation is extensively used in patients on maintenance hemodialysis (HD) to improve dialysis-related clinical symptoms. In a series of studies, we investigated the dynamics of carnitine pool in carnitine- supplemented HD patients; here we report dramatic decrease with special changes of the ester profile due to interruption of the exogenous intake after the last HD session. Serum samples were collected from 18 L-carnitine-repleted end-stage renal disease (ESRD) patients before the L-carnitine supplementation, after completion of a carnitine supplementation period treatment (12 weeks, 1 g/IV/HD), right before the HD session, and 44 h after the dialysis. Levels of free carnitine (FC) and the individual esters were determined using electrospray MS/MS technique. Normally, L-carnitine supplementation causes significant elevation of all carnitine compounds to supraphysiological levels, which reaches a standard steady-state-like profile. In this study we found a dramatic decrease in the level of FC, and in short- and medium-chain acylcarnitines (ACs) 44 h after the last dialysis. At the end of this interdialytic period, FC levels increased to only 65 of the predialysis level, whereas the amounts of C2 and C3 esters recovered to only 50. The level of C6 was 65 of the predialysis level, whereas the amount of C8 chain length ACs returned to 72 of the predialysis level. No significant change was seen in AC concentrations above C10 chain length. Omission of one single dosage of supplemental carnitine in long-term administration schemes results in dramatic decrease and reprofiling of carnitine esters even after the usual 44 h of interdialytic period.

Original languageEnglish
Pages (from-to)555-558
Number of pages4
JournalRenal Failure
Volume34
Issue number5
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Carnitine
Renal Dialysis
Esters
Dialysis
Chronic Kidney Failure

Keywords

  • Carnitine esters
  • Hemodialysis
  • L-carnitine
  • Mass spectrometry

ASJC Scopus subject areas

  • Nephrology
  • Critical Care and Intensive Care Medicine

Cite this

@article{c7e7bf76a18f49f5ac6e7fade77a2e78,
title = "Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients",
abstract = "L-carnitine supplementation is extensively used in patients on maintenance hemodialysis (HD) to improve dialysis-related clinical symptoms. In a series of studies, we investigated the dynamics of carnitine pool in carnitine- supplemented HD patients; here we report dramatic decrease with special changes of the ester profile due to interruption of the exogenous intake after the last HD session. Serum samples were collected from 18 L-carnitine-repleted end-stage renal disease (ESRD) patients before the L-carnitine supplementation, after completion of a carnitine supplementation period treatment (12 weeks, 1 g/IV/HD), right before the HD session, and 44 h after the dialysis. Levels of free carnitine (FC) and the individual esters were determined using electrospray MS/MS technique. Normally, L-carnitine supplementation causes significant elevation of all carnitine compounds to supraphysiological levels, which reaches a standard steady-state-like profile. In this study we found a dramatic decrease in the level of FC, and in short- and medium-chain acylcarnitines (ACs) 44 h after the last dialysis. At the end of this interdialytic period, FC levels increased to only 65 of the predialysis level, whereas the amounts of C2 and C3 esters recovered to only 50. The level of C6 was 65 of the predialysis level, whereas the amount of C8 chain length ACs returned to 72 of the predialysis level. No significant change was seen in AC concentrations above C10 chain length. Omission of one single dosage of supplemental carnitine in long-term administration schemes results in dramatic decrease and reprofiling of carnitine esters even after the usual 44 h of interdialytic period.",
keywords = "Carnitine esters, Hemodialysis, L-carnitine, Mass spectrometry",
author = "J. Bene and Botond Csiky and I. Wittmann and E. Sulyok and B. Melegh",
year = "2012",
month = "6",
doi = "10.3109/0886022X.2012.664509",
language = "English",
volume = "34",
pages = "555--558",
journal = "Renal Failure",
issn = "0886-022X",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients

AU - Bene, J.

AU - Csiky, Botond

AU - Wittmann, I.

AU - Sulyok, E.

AU - Melegh, B.

PY - 2012/6

Y1 - 2012/6

N2 - L-carnitine supplementation is extensively used in patients on maintenance hemodialysis (HD) to improve dialysis-related clinical symptoms. In a series of studies, we investigated the dynamics of carnitine pool in carnitine- supplemented HD patients; here we report dramatic decrease with special changes of the ester profile due to interruption of the exogenous intake after the last HD session. Serum samples were collected from 18 L-carnitine-repleted end-stage renal disease (ESRD) patients before the L-carnitine supplementation, after completion of a carnitine supplementation period treatment (12 weeks, 1 g/IV/HD), right before the HD session, and 44 h after the dialysis. Levels of free carnitine (FC) and the individual esters were determined using electrospray MS/MS technique. Normally, L-carnitine supplementation causes significant elevation of all carnitine compounds to supraphysiological levels, which reaches a standard steady-state-like profile. In this study we found a dramatic decrease in the level of FC, and in short- and medium-chain acylcarnitines (ACs) 44 h after the last dialysis. At the end of this interdialytic period, FC levels increased to only 65 of the predialysis level, whereas the amounts of C2 and C3 esters recovered to only 50. The level of C6 was 65 of the predialysis level, whereas the amount of C8 chain length ACs returned to 72 of the predialysis level. No significant change was seen in AC concentrations above C10 chain length. Omission of one single dosage of supplemental carnitine in long-term administration schemes results in dramatic decrease and reprofiling of carnitine esters even after the usual 44 h of interdialytic period.

AB - L-carnitine supplementation is extensively used in patients on maintenance hemodialysis (HD) to improve dialysis-related clinical symptoms. In a series of studies, we investigated the dynamics of carnitine pool in carnitine- supplemented HD patients; here we report dramatic decrease with special changes of the ester profile due to interruption of the exogenous intake after the last HD session. Serum samples were collected from 18 L-carnitine-repleted end-stage renal disease (ESRD) patients before the L-carnitine supplementation, after completion of a carnitine supplementation period treatment (12 weeks, 1 g/IV/HD), right before the HD session, and 44 h after the dialysis. Levels of free carnitine (FC) and the individual esters were determined using electrospray MS/MS technique. Normally, L-carnitine supplementation causes significant elevation of all carnitine compounds to supraphysiological levels, which reaches a standard steady-state-like profile. In this study we found a dramatic decrease in the level of FC, and in short- and medium-chain acylcarnitines (ACs) 44 h after the last dialysis. At the end of this interdialytic period, FC levels increased to only 65 of the predialysis level, whereas the amounts of C2 and C3 esters recovered to only 50. The level of C6 was 65 of the predialysis level, whereas the amount of C8 chain length ACs returned to 72 of the predialysis level. No significant change was seen in AC concentrations above C10 chain length. Omission of one single dosage of supplemental carnitine in long-term administration schemes results in dramatic decrease and reprofiling of carnitine esters even after the usual 44 h of interdialytic period.

KW - Carnitine esters

KW - Hemodialysis

KW - L-carnitine

KW - Mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=84860715312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860715312&partnerID=8YFLogxK

U2 - 10.3109/0886022X.2012.664509

DO - 10.3109/0886022X.2012.664509

M3 - Article

VL - 34

SP - 555

EP - 558

JO - Renal Failure

JF - Renal Failure

SN - 0886-022X

IS - 5

ER -